These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

409 related articles for article (PubMed ID: 16411893)

  • 21. Neuronal and nonneuronal expression of neurotrophins and their receptors in sensory and sympathetic ganglia suggest new intercellular trophic interactions.
    Wetmore C; Olson L
    J Comp Neurol; 1995 Feb; 353(1):143-59. PubMed ID: 7714245
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differential distribution of exogenous BDNF, NGF, and NT-3 in the brain corresponds to the relative abundance and distribution of high-affinity and low-affinity neurotrophin receptors.
    Anderson KD; Alderson RF; Altar CA; DiStefano PS; Corcoran TL; Lindsay RM; Wiegand SJ
    J Comp Neurol; 1995 Jun; 357(2):296-317. PubMed ID: 7665731
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Multipotent neurotrophin antagonist targets brain-derived neurotrophic factor and nerve growth factor.
    Eibl JK; Chapelsky SA; Ross GM
    J Pharmacol Exp Ther; 2010 Feb; 332(2):446-54. PubMed ID: 19923440
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Advances in small molecules promoting neurotrophic function.
    Price RD; Milne SA; Sharkey J; Matsuoka N
    Pharmacol Ther; 2007 Aug; 115(2):292-306. PubMed ID: 17599430
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differential dependency of cutaneous mechanoreceptors on neurotrophins, trk receptors, and P75 LNGFR.
    Fundin BT; Silos-Santiago I; Ernfors P; Fagan AM; Aldskogius H; DeChiara TM; Phillips HS; Barbacid M; Yancopoulos GD; Rice FL
    Dev Biol; 1997 Oct; 190(1):94-116. PubMed ID: 9331334
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development of Precision Small-Molecule Proneurotrophic Therapies for Neurodegenerative Diseases.
    Janssens J; Lu D; Ni B; Chadwick W; Siddiqui S; Azmi A; Etienne H; Jushaj A; van Gastel J; Martin B; Maudsley S
    Vitam Horm; 2017; 104():263-311. PubMed ID: 28215298
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Neurotrophins. I: Molecular features].
    Zazpe A; Del Río J
    Rev Med Univ Navarra; 1997; 41(3):173-9. PubMed ID: 10420923
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differences in the surface binding and endocytosis of neurotrophins by p75NTR.
    Saxena S; Howe CL; Cosgaya JM; Hu M; Weis J; Krüttgen A
    Mol Cell Neurosci; 2004 Jun; 26(2):292-307. PubMed ID: 15207854
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differences in early and late responses between neurotrophin-stimulated trkA- and trkC-transfected SH-SY5Y neuroblastoma cells.
    Edsjö A; Hallberg B; Fagerström S; Larsson C; Axelson H; Påhlman S
    Cell Growth Differ; 2001 Jan; 12(1):39-50. PubMed ID: 11205744
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Proteasomal inhibition alters the trafficking of the neurotrophin receptor TrkA.
    Moises T; Wüller S; Saxena S; Senderek J; Weis J; Krüttgen A
    Biochem Biophys Res Commun; 2009 Sep; 387(2):360-4. PubMed ID: 19607811
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of neurotrophin signalling in the differentiation of neurons from dorsal root ganglia and sympathetic ganglia.
    Ernsberger U
    Cell Tissue Res; 2009 Jun; 336(3):349-84. PubMed ID: 19387688
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Function and evolution in the NGF family and its receptors.
    Ebendal T
    J Neurosci Res; 1992 Aug; 32(4):461-70. PubMed ID: 1326636
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of neurotrophic factors in behavioral processes: implications for the treatment of psychiatric and neurodegenerative disorders.
    Pardon MC
    Vitam Horm; 2010; 82():185-200. PubMed ID: 20472139
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Neurotrophins and their receptors in tumors].
    Vladychenskaia IP; Dergunova LV; Limborskaia SA
    Mol Gen Mikrobiol Virusol; 2006; (3):16-22. PubMed ID: 16941843
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neurotrophin Signaling and Stem Cells-Implications for Neurodegenerative Diseases and Stem Cell Therapy.
    Pramanik S; Sulistio YA; Heese K
    Mol Neurobiol; 2017 Nov; 54(9):7401-7459. PubMed ID: 27815842
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neurotrophins: mediators and modulators of pain.
    Pezet S; McMahon SB
    Annu Rev Neurosci; 2006; 29():507-38. PubMed ID: 16776595
    [TBL] [Abstract][Full Text] [Related]  

  • 37. GDNF, NGF and BDNF as therapeutic options for neurodegeneration.
    Allen SJ; Watson JJ; Shoemark DK; Barua NU; Patel NK
    Pharmacol Ther; 2013 May; 138(2):155-75. PubMed ID: 23348013
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Exploring the Therapeutic Effect of Neurotrophins and Neuropeptides in Neurodegenerative Diseases: at a Glance.
    Rahman MM; Islam MR; Supti FA; Dhar PS; Shohag S; Ferdous J; Shuvo SK; Akter A; Hossain MS; Sharma R
    Mol Neurobiol; 2023 Aug; 60(8):4206-4231. PubMed ID: 37052791
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Alterations in neurotrophins and neurotrophin receptors in Alzheimer's disease.
    Hock CH; Heese K; Olivieri G; Hulette CH; Rosenberg C; Nitsch RM; Otten U
    J Neural Transm Suppl; 2000; 59():171-4. PubMed ID: 10961429
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Targeting neurotrophin receptors in the central nervous system.
    Mocchetti I; Brown M
    CNS Neurol Disord Drug Targets; 2008 Feb; 7(1):71-82. PubMed ID: 18289034
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.